Events and presentations Featured March 10, 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference 2026 March 10, 2026 Read more → March 10, 2026 January 28, 2026 NMD Pharma at J. P. Morgan Healthcare Conference 2026 January 28, 2026 Read more → January 28, 2026 May 29, 2025 We’re proud to share a special video marking NMD Pharma’s 10-year anniversary May 29, 2025 Read more → May 29, 2025 February 27, 2025 NMD Pharma raises awareness ahead of Rare Disease Day, 2025 February 27, 2025 Read more → February 27, 2025 November 30, 2024 ClC-1 inhibition for improvement of muscle function in CMT webinar November 30, 2024 Read more → November 30, 2024 April 25, 2024 Watch Cure SMA's Clinical Trial Update Webinar with NMD Pharma April 25, 2024 Read more → April 25, 2024 March 21, 2024 NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine March 21, 2024 Read more → March 21, 2024 February 28, 2023 Rare Disease Day, 28 February 2023 February 28, 2023 Read more → February 28, 2023 October 11, 2022 Today we are able to announce positive topline data from our Phase I/IIa clinical trial of NMD670 in patients with Myasthenia Gravis October 11, 2022 Read more → October 11, 2022 August 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 1 August 16, 2022 Read more → August 16, 2022 August 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 2 August 16, 2022 Read more → August 16, 2022 August 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 3 August 16, 2022 Read more → August 16, 2022 August 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 4 - Q&A August 16, 2022 Read more → August 16, 2022 July 7, 2022 An active future made possible by the power of science July 7, 2022 Read more → July 7, 2022
